Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2022-10-07 Director's Dealing
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Allegato 3F - Settembre
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI" / "MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES". It details transactions (purchases/sales, indicated by 'A' for Acquisto/Buy in column 3.1) involving the issuer's shares (PHILOGEN S.p.A.) during a specific reference period (09/2022). This structure is characteristic of mandatory regulatory filings reporting insider or related-party transactions in the company's own stock. Among the provided definitions, 'Director's Dealing' (DIRS) covers personal share transactions by directors, but this specific form seems to be a broader disclosure of transactions in the issuer's securities, often related to management or major shareholders, which falls under the scope of insider trading reports or similar mandatory disclosures. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting transactions in the issuer's securities, although the document title suggests a general transaction disclosure schema. However, the most specific category for reporting transactions by insiders (directors/executives) is DIRS. If this were a general company transaction (like a buyback), POS would apply, but the format strongly suggests an individual/insider disclosure schema. Since the document explicitly details transactions in the issuer's securities by a party identified in Section 1, DIRS is the most appropriate classification for insider transaction reporting.
2022-10-07 Italian
2022 09 30 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 100% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. during a specific period (September 26, 2022, to September 30, 2022). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is an update/report, the content is the transaction detail itself, not just an announcement that a report is available (which would suggest RPA or RNS).
2022-10-03 Italian
Half Year Report 2021 as of 30.06.2022 (Courtesy English Translation)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Interim Management Report' as of June 30, 2022, for Philogen S.p.A. It includes detailed sections on corporate bodies, group strategy, interim management analysis, and condensed consolidated financial statements (income statement, balance sheet, cash flows, and notes). Since it covers a period shorter than a full fiscal year and contains substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2022
2022-09-30 English
Relazione Finanziaria Semestrale al 30.06.2022
Interim / Quarterly Report Classification · 100% confidence The document is a 'Relazione intermedia sulla gestione al 30 giugno 2022' (Interim Management Report as of June 30, 2022) for Philogen. It contains comprehensive financial statements, including the consolidated balance sheet, income statement, cash flow statement, and explanatory notes for the first half of the fiscal year. It is clearly a substantive financial report rather than an announcement or a certification, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-09-30 Italian
The Board of Directors Approves the Half-Yearly Financial Report at 30 June 2022 (Price sensitive) – Courtesy English Translation
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the half-year period ending June 30, 2022. It contains detailed consolidated financial statements, including income statements, balance sheet data, and net financial position tables, as well as management's discussion and analysis of the results. It is not a mere announcement (RPA) because it provides substantive financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report. H1 2022
2022-09-28 English
Il Consiglio di Amministrazione Approva la Relazione Finanziaria Semestrale al 30 giugno 2022 (Price sensitive)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the six-month period ending June 30, 2022, titled 'Relazione Finanziaria Semestrale'. It contains detailed financial statements, including income statement highlights (EBITDA, EBIT, Net Result), balance sheet data, and a detailed breakdown of the Net Financial Position (Indebitamento Finanziario Netto) in accordance with ESMA guidelines. It also includes management commentary on business performance and future outlook. As it provides substantive financial data for an interim period, it is classified as an Interim/Quarterly Report. H1 2022
2022-09-28 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.